List of Tables
Table 1. Global NASH Drug Pipeline Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global NASH Drug Pipeline Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global NASH Drug Pipeline Market Competitive Situation by Manufacturers in 2024
Table 4. Global NASH Drug Pipeline Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global NASH Drug Pipeline Sales Market Share by Manufacturers (2020-2025)
Table 6. Global NASH Drug Pipeline Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global NASH Drug Pipeline Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market NASH Drug Pipeline Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of NASH Drug Pipeline, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of NASH Drug Pipeline, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of NASH Drug Pipeline, Product Type & Application
Table 12. Global Key Manufacturers of NASH Drug Pipeline, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global NASH Drug Pipeline by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Drug Pipeline as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global NASH Drug Pipeline Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global NASH Drug Pipeline Sales by Region (2020-2025) & (K Units)
Table 18. Global NASH Drug Pipeline Sales Market Share by Region (2020-2025)
Table 19. Global NASH Drug Pipeline Sales by Region (2026-2031) & (K Units)
Table 20. Global NASH Drug Pipeline Sales Market Share by Region (2026-2031)
Table 21. Global NASH Drug Pipeline Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global NASH Drug Pipeline Revenue Market Share by Region (2020-2025)
Table 23. Global NASH Drug Pipeline Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global NASH Drug Pipeline Revenue Market Share by Region (2026-2031)
Table 25. North America NASH Drug Pipeline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America NASH Drug Pipeline Sales by Country (2020-2025) & (K Units)
Table 27. North America NASH Drug Pipeline Sales by Country (2026-2031) & (K Units)
Table 28. North America NASH Drug Pipeline Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America NASH Drug Pipeline Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe NASH Drug Pipeline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe NASH Drug Pipeline Sales by Country (2020-2025) & (K Units)
Table 32. Europe NASH Drug Pipeline Sales by Country (2026-2031) & (K Units)
Table 33. Europe NASH Drug Pipeline Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe NASH Drug Pipeline Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific NASH Drug Pipeline Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific NASH Drug Pipeline Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific NASH Drug Pipeline Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific NASH Drug Pipeline Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific NASH Drug Pipeline Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America NASH Drug Pipeline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America NASH Drug Pipeline Sales by Country (2020-2025) & (K Units)
Table 42. Latin America NASH Drug Pipeline Sales by Country (2026-2031) & (K Units)
Table 43. Latin America NASH Drug Pipeline Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America NASH Drug Pipeline Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa NASH Drug Pipeline Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa NASH Drug Pipeline Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa NASH Drug Pipeline Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa NASH Drug Pipeline Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa NASH Drug Pipeline Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global NASH Drug Pipeline Sales (K Units) by Type (2020-2025)
Table 51. Global NASH Drug Pipeline Sales (K Units) by Type (2026-2031)
Table 52. Global NASH Drug Pipeline Sales Market Share by Type (2020-2025)
Table 53. Global NASH Drug Pipeline Sales Market Share by Type (2026-2031)
Table 54. Global NASH Drug Pipeline Revenue (US$ Million) by Type (2020-2025)
Table 55. Global NASH Drug Pipeline Revenue (US$ Million) by Type (2026-2031)
Table 56. Global NASH Drug Pipeline Revenue Market Share by Type (2020-2025)
Table 57. Global NASH Drug Pipeline Revenue Market Share by Type (2026-2031)
Table 58. Global NASH Drug Pipeline Price (US$/Unit) by Type (2020-2025)
Table 59. Global NASH Drug Pipeline Price (US$/Unit) by Type (2026-2031)
Table 60. Global NASH Drug Pipeline Sales (K Units) by Application (2020-2025)
Table 61. Global NASH Drug Pipeline Sales (K Units) by Application (2026-2031)
Table 62. Global NASH Drug Pipeline Sales Market Share by Application (2020-2025)
Table 63. Global NASH Drug Pipeline Sales Market Share by Application (2026-2031)
Table 64. Global NASH Drug Pipeline Revenue (US$ Million) by Application (2020-2025)
Table 65. Global NASH Drug Pipeline Revenue (US$ Million) by Application (2026-2031)
Table 66. Global NASH Drug Pipeline Revenue Market Share by Application (2020-2025)
Table 67. Global NASH Drug Pipeline Revenue Market Share by Application (2026-2031)
Table 68. Global NASH Drug Pipeline Price (US$/Unit) by Application (2020-2025)
Table 69. Global NASH Drug Pipeline Price (US$/Unit) by Application (2026-2031)
Table 70. Intercept Company Information
Table 71. Intercept Description and Business Overview
Table 72. Intercept NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Intercept NASH Drug Pipeline Product
Table 74. Intercept Recent Developments/Updates
Table 75. Genfit Company Information
Table 76. Genfit Description and Business Overview
Table 77. Genfit NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Genfit NASH Drug Pipeline Product
Table 79. Genfit Recent Developments/Updates
Table 80. Allergan Company Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Allergan NASH Drug Pipeline Product
Table 84. Allergan Recent Developments/Updates
Table 85. Madrigal Company Information
Table 86. Madrigal Description and Business Overview
Table 87. Madrigal NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Madrigal NASH Drug Pipeline Product
Table 89. Madrigal Recent Developments/Updates
Table 90. Immuron Company Information
Table 91. Immuron Description and Business Overview
Table 92. Immuron NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Immuron NASH Drug Pipeline Product
Table 94. Immuron Recent Developments/Updates
Table 95. Galectin Company Information
Table 96. Galectin Description and Business Overview
Table 97. Galectin NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Galectin NASH Drug Pipeline Product
Table 99. Galectin Recent Developments/Updates
Table 100. Gilead Company Information
Table 101. Gilead Description and Business Overview
Table 102. Gilead NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Gilead NASH Drug Pipeline Product
Table 104. Gilead Recent Developments/Updates
Table 105. 89bio Inc Company Information
Table 106. 89bio Inc Description and Business Overview
Table 107. 89bio Inc NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. 89bio Inc NASH Drug Pipeline Product
Table 109. 89bio Inc Recent Developments/Updates
Table 110. ABIONYX Pharma SA Company Information
Table 111. ABIONYX Pharma SA Description and Business Overview
Table 112. ABIONYX Pharma SA NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. ABIONYX Pharma SA NASH Drug Pipeline Product
Table 114. ABIONYX Pharma SA Recent Developments/Updates
Table 115. Abivax SA Company Information
Table 116. Abivax SA Description and Business Overview
Table 117. Abivax SA NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Abivax SA NASH Drug Pipeline Product
Table 119. Abivax SA Recent Developments/Updates
Table 120. Abliva AB Company Information
Table 121. Abliva AB Description and Business Overview
Table 122. Abliva AB NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Abliva AB NASH Drug Pipeline Product
Table 124. Abliva AB Recent Developments/Updates
Table 125. Acquist Therapeutics Company Information
Table 126. Acquist Therapeutics Description and Business Overview
Table 127. Acquist Therapeutics NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Acquist Therapeutics NASH Drug Pipeline Product
Table 129. Acquist Therapeutics Recent Developments/Updates
Table 130. AdAlta Ltd Company Information
Table 131. AdAlta Ltd Description and Business Overview
Table 132. AdAlta Ltd NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. AdAlta Ltd NASH Drug Pipeline Product
Table 134. AdAlta Ltd Recent Developments/Updates
Table 135. Afimmune Biopharma Ltd Company Information
Table 136. Afimmune Biopharma Ltd Description and Business Overview
Table 137. Afimmune Biopharma Ltd NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Afimmune Biopharma Ltd NASH Drug Pipeline Product
Table 139. Afimmune Biopharma Ltd Recent Developments/Updates
Table 140. Zhejiang Doer Biologics Corp Company Information
Table 141. Zhejiang Doer Biologics Corp Description and Business Overview
Table 142. Zhejiang Doer Biologics Corp NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Zhejiang Doer Biologics Corp NASH Drug Pipeline Product
Table 144. Zhejiang Doer Biologics Corp Recent Developments/Updates
Table 145. Dicerna Pharmaceuticals Inc Company Information
Table 146. Dicerna Pharmaceuticals Inc Description and Business Overview
Table 147. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Product
Table 149. Dicerna Pharmaceuticals Inc Recent Developments/Updates
Table 150. ChemomAb Ltd Company Information
Table 151. ChemomAb Ltd Description and Business Overview
Table 152. ChemomAb Ltd NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. ChemomAb Ltd NASH Drug Pipeline Product
Table 154. ChemomAb Ltd Recent Developments/Updates
Table 155. DURECT Corp Company Information
Table 156. DURECT Corp Description and Business Overview
Table 157. DURECT Corp NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. DURECT Corp NASH Drug Pipeline Product
Table 159. DURECT Corp Recent Developments/Updates
Table 160. Eli Lilly and Co Company Information
Table 161. Eli Lilly and Co Description and Business Overview
Table 162. Eli Lilly and Co NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Eli Lilly and Co NASH Drug Pipeline Product
Table 164. Eli Lilly and Co Recent Developments/Updates
Table 165. Enanta Pharmaceuticals Inc Company Information
Table 166. Enanta Pharmaceuticals Inc Description and Business Overview
Table 167. Enanta Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Enanta Pharmaceuticals Inc NASH Drug Pipeline Product
Table 169. Enanta Pharmaceuticals Inc Recent Developments/Updates
Table 170. EncuraGen Inc Company Information
Table 171. EncuraGen Inc Description and Business Overview
Table 172. EncuraGen Inc NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. EncuraGen Inc NASH Drug Pipeline Product
Table 174. EncuraGen Inc Recent Developments/Updates
Table 175. Engitix Ltd Company Information
Table 176. Engitix Ltd Description and Business Overview
Table 177. Engitix Ltd NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Engitix Ltd NASH Drug Pipeline Product
Table 179. Engitix Ltd Recent Developments/Updates
Table 180. Heprotech Inc Company Information
Table 181. Heprotech Inc Description and Business Overview
Table 182. Heprotech Inc NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Heprotech Inc NASH Drug Pipeline Product
Table 184. Heprotech Inc Recent Developments/Updates
Table 185. Hinova Pharmaceuticals Inc Company Information
Table 186. Hinova Pharmaceuticals Inc Description and Business Overview
Table 187. Hinova Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Hinova Pharmaceuticals Inc NASH Drug Pipeline Product
Table 189. Hinova Pharmaceuticals Inc Recent Developments/Updates
Table 190. HK inno.N Corp Company Information
Table 191. HK inno.N Corp Description and Business Overview
Table 192. HK inno.N Corp NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. HK inno.N Corp NASH Drug Pipeline Product
Table 194. HK inno.N Corp Recent Developments/Updates
Table 195. HotSpot Therapeutics Inc Company Information
Table 196. HotSpot Therapeutics Inc Description and Business Overview
Table 197. HotSpot Therapeutics Inc NASH Drug Pipeline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 198. HotSpot Therapeutics Inc NASH Drug Pipeline Product
Table 199. HotSpot Therapeutics Inc Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. NASH Drug Pipeline Distributors List
Table 203. NASH Drug Pipeline Customers List
Table 204. NASH Drug Pipeline Market Trends
Table 205. NASH Drug Pipeline Market Drivers
Table 206. NASH Drug Pipeline Market Challenges
Table 207. NASH Drug Pipeline Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
Table 211. Authors List of This Report
List of Figures
Figure 1. Product Picture of NASH Drug Pipeline
Figure 2. Global NASH Drug Pipeline Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NASH Drug Pipeline Market Share by Type: 2024 & 2031
Figure 4. By Mechanism of Action Product Picture
Figure 5. By Molecule Types Product Picture
Figure 6. By Route of Administration: Product Picture
Figure 7. Global NASH Drug Pipeline Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global NASH Drug Pipeline Market Share by Application: 2024 & 2031
Figure 9. Clinical
Figure 10. Academic Research
Figure 11. Global NASH Drug Pipeline Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global NASH Drug Pipeline Market Size (2020-2031) & (US$ Million)
Figure 13. Global NASH Drug Pipeline Sales (2020-2031) & (K Units)
Figure 14. Global NASH Drug Pipeline Average Price (US$/Unit) & (2020-2031)
Figure 15. NASH Drug Pipeline Report Years Considered
Figure 16. NASH Drug Pipeline Sales Share by Manufacturers in 2024
Figure 17. Global NASH Drug Pipeline Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest NASH Drug Pipeline Players: Market Share by Revenue in NASH Drug Pipeline in 2024
Figure 19. NASH Drug Pipeline Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global NASH Drug Pipeline Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America NASH Drug Pipeline Sales Market Share by Country (2020-2031)
Figure 22. North America NASH Drug Pipeline Revenue Market Share by Country (2020-2031)
Figure 23. United States NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe NASH Drug Pipeline Sales Market Share by Country (2020-2031)
Figure 26. Europe NASH Drug Pipeline Revenue Market Share by Country (2020-2031)
Figure 27. Germany NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific NASH Drug Pipeline Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific NASH Drug Pipeline Revenue Market Share by Region (2020-2031)
Figure 34. China NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America NASH Drug Pipeline Sales Market Share by Country (2020-2031)
Figure 44. Latin America NASH Drug Pipeline Revenue Market Share by Country (2020-2031)
Figure 45. Mexico NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa NASH Drug Pipeline Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa NASH Drug Pipeline Revenue Market Share by Country (2020-2031)
Figure 50. Turkey NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE NASH Drug Pipeline Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of NASH Drug Pipeline by Type (2020-2031)
Figure 54. Global Revenue Market Share of NASH Drug Pipeline by Type (2020-2031)
Figure 55. Global NASH Drug Pipeline Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of NASH Drug Pipeline by Application (2020-2031)
Figure 57. Global Revenue Market Share of NASH Drug Pipeline by Application (2020-2031)
Figure 58. Global NASH Drug Pipeline Price (US$/Unit) by Application (2020-2031)
Figure 59. NASH Drug Pipeline Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
